Filters

Drugs

Showing results (3181-3190 of 7,131) with videos related to

Pageof 714
Sort By:
Drugs|January 10, 2020
Potential of Lipoprotein(a)-Lowering Strategies in Treating Coronary Artery DiseaseBaris Gencer, François Mach
Drugs|February 21, 2020
Human Epidermal Growth Factor Receptor 2 (HER2) in Advanced Gastric Cancer: Current Knowledge and Future PerspectivesJuliette Palle, Adrien Rochand, Simon Pernot, et al.
Drugs|January 1, 1986
Endocrine mechanisms in congestive cardiac failure. Renin, aldosterone and atrial natriuretic hormoneJ H Laragh
Drugs|January 1, 1988
The future of pharmacological therapy for risk factor reduction. HypertensionL Hansson
Drugs|January 1, 1988
The future of pharmacological therapy for risk factor reduction. HyperlipidaemiaA G Olsson, J Mölgaard
Drugs|January 1, 1988
Experiences from hypertension trials. Impact of other risk factorsO Samuelsson
Drugs|January 1, 1988
Clinical pharmacology and pharmacokinetic properties of topically applied corticosteroids. A reviewK L Goa
Drugs|August 1, 1988
Milrinone. A preliminary review of its pharmacological properties and therapeutic useR A Young, A Ward
Drugs|January 1, 1987
Rational use of analgesics in the treatment of the rheumatic disordersF D Hart
Drugs|October 1, 1988
Xamoterol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic useR Furlong, R N Brogden
Pageof 714

Showing results (3181-3190 of 7,131) with videos related to

Sort By:
Pageof 714
Drugs|January 10, 2020
Potential of Lipoprotein(a)-Lowering Strategies in Treating Coronary Artery DiseaseBaris Gencer, François Mach
Drugs|February 21, 2020
Human Epidermal Growth Factor Receptor 2 (HER2) in Advanced Gastric Cancer: Current Knowledge and Future PerspectivesJuliette Palle, Adrien Rochand, Simon Pernot, et al.
Drugs|January 1, 1986
Endocrine mechanisms in congestive cardiac failure. Renin, aldosterone and atrial natriuretic hormoneJ H Laragh
Drugs|January 1, 1988
The future of pharmacological therapy for risk factor reduction. HypertensionL Hansson
Drugs|January 1, 1988
The future of pharmacological therapy for risk factor reduction. HyperlipidaemiaA G Olsson, J Mölgaard
Drugs|January 1, 1988
Experiences from hypertension trials. Impact of other risk factorsO Samuelsson
Drugs|January 1, 1988
Clinical pharmacology and pharmacokinetic properties of topically applied corticosteroids. A reviewK L Goa
Drugs|August 1, 1988
Milrinone. A preliminary review of its pharmacological properties and therapeutic useR A Young, A Ward
Drugs|January 1, 1987
Rational use of analgesics in the treatment of the rheumatic disordersF D Hart
Drugs|October 1, 1988
Xamoterol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic useR Furlong, R N Brogden
Pageof 714
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us